|Catalog No.||Product Name||Information||Selective / Pan||IC50 / Ki|
CU-CPT22 shows dose-dependent inhibitory effects blocking Pam3CSK4-induced TLR1/2 activation with an IC50 of 0.58 ± 0.09 µM while no significant inhibition to TLR2/6. It demonstrates minimal non-specific inhibition against a panel of 10 representative kinases (PDGFRB, MET, DDR2, SRC, MAPK1, PAK1, AKT1, PKC-γ, CAMK1, and PLK4).
|Pan||TLR1/2, IC50: 0.58 μM|
There are no products matching the selection yet, if you have any question please do not hesitate to contact us.